Logo image of FLGT

FULGENT GENETICS INC (FLGT) Stock Fundamental Analysis

USA - NASDAQ:FLGT - US3596641098 - Common Stock

22.29 USD
+0.19 (+0.86%)
Last: 9/25/2025, 1:15:50 PM
Fundamental Rating

4

Overall FLGT gets a fundamental rating of 4 out of 10. We evaluated FLGT against 101 industry peers in the Health Care Providers & Services industry. While FLGT seems to be doing ok healthwise, there are quite some concerns on its profitability. FLGT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

FLGT had positive earnings in the past year.
In the past year FLGT has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: FLGT reported negative net income in multiple years.
Each year in the past 5 years FLGT had a positive operating cash flow.
FLGT Yearly Net Income VS EBIT VS OCF VS FCFFLGT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

FLGT has a worse Return On Assets (-4.25%) than 63.37% of its industry peers.
FLGT has a Return On Equity (-4.57%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.25%
ROE -4.57%
ROIC N/A
ROA(3y)-2.25%
ROA(5y)12.71%
ROE(3y)-2.41%
ROE(5y)14.84%
ROIC(3y)N/A
ROIC(5y)N/A
FLGT Yearly ROA, ROE, ROICFLGT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With a decent Gross Margin value of 40.04%, FLGT is doing good in the industry, outperforming 69.31% of the companies in the same industry.
In the last couple of years the Gross Margin of FLGT has declined.
The Profit Margin and Operating Margin are not available for FLGT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.53%
GM growth 5Y-7.75%
FLGT Yearly Profit, Operating, Gross MarginsFLGT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

FLGT does not have a ROIC to compare to the WACC, probably because it is not profitable.
FLGT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FLGT has been increased compared to 5 years ago.
Compared to 1 year ago, FLGT has an improved debt to assets ratio.
FLGT Yearly Shares OutstandingFLGT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
FLGT Yearly Total Debt VS Total AssetsFLGT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

FLGT has an Altman-Z score of 5.94. This indicates that FLGT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.94, FLGT belongs to the top of the industry, outperforming 86.14% of the companies in the same industry.
FLGT has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
FLGT has a better Debt to Equity ratio (0.00) than 87.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.94
ROIC/WACCN/A
WACC8.76%
FLGT Yearly LT Debt VS Equity VS FCFFLGT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 6.01 indicates that FLGT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.01, FLGT belongs to the top of the industry, outperforming 94.06% of the companies in the same industry.
A Quick Ratio of 6.01 indicates that FLGT has no problem at all paying its short term obligations.
FLGT has a Quick ratio of 6.01. This is amongst the best in the industry. FLGT outperforms 94.06% of its industry peers.
Industry RankSector Rank
Current Ratio 6.01
Quick Ratio 6.01
FLGT Yearly Current Assets VS Current LiabilitesFLGT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1433.33% over the past year.
FLGT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.18% yearly.
The Revenue has been growing slightly by 4.30% in the past year.
Measured over the past years, FLGT shows a very strong growth in Revenue. The Revenue has been growing by 54.21% on average per year.
EPS 1Y (TTM)1433.33%
EPS 3Y-68.94%
EPS 5Y22.18%
EPS Q2Q%-53.33%
Revenue 1Y (TTM)4.3%
Revenue growth 3Y-34.15%
Revenue growth 5Y54.21%
Sales Q2Q%15.17%

3.2 Future

The Earnings Per Share is expected to decrease by -40.44% on average over the next years. This is quite bad
The Revenue is expected to grow by 11.14% on average over the next years. This is quite good.
EPS Next Y-192.98%
EPS Next 2Y-83.3%
EPS Next 3Y-40.44%
EPS Next 5YN/A
Revenue Next Year12.97%
Revenue Next 2Y11.77%
Revenue Next 3Y11.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FLGT Yearly Revenue VS EstimatesFLGT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
FLGT Yearly EPS VS EstimatesFLGT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 48.46, FLGT can be considered very expensive at the moment.
FLGT's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of FLGT to the average of the S&P500 Index (27.29), we can say FLGT is valued expensively.
FLGT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 48.46
Fwd PE N/A
FLGT Price Earnings VS Forward Price EarningsFLGT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLGT Per share dataFLGT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A cheap valuation may be justified as FLGT's earnings are expected to decrease with -40.44% in the coming years.
PEG (NY)N/A
PEG (5Y)2.19
EPS Next 2Y-83.3%
EPS Next 3Y-40.44%

More info and screens

0

5. Dividend

5.1 Amount

FLGT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FULGENT GENETICS INC

NASDAQ:FLGT (9/25/2025, 1:15:50 PM)

22.29

+0.19 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners54.79%
Inst Owner Change-0.07%
Ins Owners33.39%
Ins Owner Change-0.44%
Market Cap682.30M
Analysts80
Price Target25.84 (15.93%)
Short Float %10.03%
Short Ratio7.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)129.32%
Min EPS beat(2)121.2%
Max EPS beat(2)137.43%
EPS beat(4)4
Avg EPS beat(4)172.16%
Min EPS beat(4)121.2%
Max EPS beat(4)298.21%
EPS beat(8)7
Avg EPS beat(8)139.31%
EPS beat(12)11
Avg EPS beat(12)145.2%
EPS beat(16)15
Avg EPS beat(16)113.81%
Revenue beat(2)2
Avg Revenue beat(2)3.16%
Min Revenue beat(2)1.07%
Max Revenue beat(2)5.24%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-1.93%
Max Revenue beat(4)5.24%
Revenue beat(8)5
Avg Revenue beat(8)4.41%
Revenue beat(12)9
Avg Revenue beat(12)6.22%
Revenue beat(16)12
Avg Revenue beat(16)6.53%
PT rev (1m)15.15%
PT rev (3m)11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.56%
EPS NY rev (1m)0%
EPS NY rev (3m)18.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.04%
Valuation
Industry RankSector Rank
PE 48.46
Fwd PE N/A
P/S 2.25
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)0.46
EY2.06%
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-1.96
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS9.91
BVpS36.48
TBVpS31.48
PEG (NY)N/A
PEG (5Y)2.19
Profitability
Industry RankSector Rank
ROA -4.25%
ROE -4.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.04%
FCFM N/A
ROA(3y)-2.25%
ROA(5y)12.71%
ROE(3y)-2.41%
ROE(5y)14.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.53%
GM growth 5Y-7.75%
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 144.73%
Cap/Sales 11.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.01
Quick Ratio 6.01
Altman-Z 5.94
F-Score6
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)101.39%
Cap/Depr(5y)338.11%
Cap/Sales(3y)8.31%
Cap/Sales(5y)7.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1433.33%
EPS 3Y-68.94%
EPS 5Y22.18%
EPS Q2Q%-53.33%
EPS Next Y-192.98%
EPS Next 2Y-83.3%
EPS Next 3Y-40.44%
EPS Next 5YN/A
Revenue 1Y (TTM)4.3%
Revenue growth 3Y-34.15%
Revenue growth 5Y54.21%
Sales Q2Q%15.17%
Revenue Next Year12.97%
Revenue Next 2Y11.77%
Revenue Next 3Y11.14%
Revenue Next 5YN/A
EBIT growth 1Y-1.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.56%
EBIT Next 3Y25.57%
EBIT Next 5YN/A
FCF growth 1Y-290.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-144.97%
OCF growth 3Y-66.06%
OCF growth 5Y30.8%